Hsp40 and Hsp70 in Membrane Protein Triage
Hsp40 and Hsp70 in Membrane Protein Triage
批准号:
10718226
负责人:
DOUGLAS M CYR
金额:
$42.23万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-01 至 2027-06-30
关键词:
ATP phosphohydrolaseATP-Binding Cassette TransportersAdoptedAmyloidAttentionAutophagocytosisAutophagosomeBenignBindingBiochemicalBiogenesisBiological AssayBiosynthetic ProteinsBlindnessCell SurvivalCell physiologyCellsClientComplexCystic FibrosisCytoplasmCytosolDataDetergentsDiameterDiseaseDistalDockingEndoplasmic ReticulumEnsureEventExhibitsExperimental DesignsFaceG-Protein-Coupled ReceptorsGoalsHealthHumanImageInduction of ApoptosisInferiorInheritedIntermediate resistanceInterstitial Lung DiseasesKineticsKlinefelter&aposs SyndromeLengthLightLocationLysosomesMaintenanceMembraneMembrane Protein TrafficMembrane ProteinsMicrotubulesMissense MutationMolecular ChaperonesMovementMutatePaintPeptidesPhosphatidylinositolsPhosphotransferasesPoisonProcessProteinsProteomePulmonary FibrosisQuality ControlResistanceRetinitis PigmentosaRoleSeriesShapesSideSiteSurfaceSystemTestingThermodynamicsTriageTubular formationWD RepeatWorkYeastscell motilityconformerexperimental studyfarnesylationhuman diseaselive cell imaginglysosomal proteinslysosome membranemanmetermisfolded proteinmulticatalytic endopeptidase complexmutantnon-Nativepolypeptideprematurepreventprotein aggregationprotein degradationprotein foldingprotein misfoldingproteotoxicityreceptorreceptor functionrecruitrestraintscreeningtherapy developmentubiquitin-protein ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary:
Membrane protein (MP) biogenesis begins in the endoplasmic reticulum (ER) and is a complex process, as
domains on both sides of the ER membrane, and within the membrane bilayer, must fold and assemble. MPs
understudy include ABC-Transporters, P-Type ATPases, G-protein coupled receptors, and BRICHOS proteins.
Missense mutations that cause misfolding and premature degradation of MPs give rise to diseases such as
cystic fibrosis, hypogonadotropic hypogonadism, retinitis pigmentosa and idiopathic lung fibrosis. In order to
prevent toxic accumulation, misfolded MPs are targeted for ER-associated degradation (ERAD) by E3 ubiquitin
ligase complexes. The ER transmembrane Hsp40 DNAJB12 (JB12) recruits cytosolic Hsp70 to the
cytoplasmic face of the ER and together these chaperones deliver the misfolded MPs to ERAD machinery. In
order for a misfolded protein to be a candidate for ERAD however, it must be competent for extraction from the
confines of the ER membrane and delivered to the cytosolic proteasome. Misfolded proteins with structural
restraints that prevent entrance into the proteasome necessitate an alternative quality control mechanism to
ensure degradation. Misfolded MPs expose surfaces in the ER lumen, membrane, and the cytosol, so the
coordinated action of ERQC factors in different locations manage this challenge. Mistakes in MP protein
management are fatal when rogue clients adopt a toxic shape that enable rogues to damage membranes and
dominantly poison essential cell functions. Hsp70 and Hsp40s act with folding and degradation machines to
triage MPs. They shield against proteotoxicity through suppressing aggregation, refolding clients, selection of
clients for degradation and regulating flux though protein biosynthetic systems. A major problem to ERQC
systems are the MPs that accumulate in thermodynamically stable intermediate states that are non-native and
self-associate to form oligomers, amorphous aggregates, and amyloid-like fibrils. Such misfolded conformers
bury surfaces that are normally recognized by ERQC factors, and their thermodynamic stability hinders the
unfolding events required for their extraction from membranes and degradation in the narrow central cavity of
the proteasome. Thermodynamically stable MP intermediates are resistant to ERAD and we discovered that
they are degraded by a JB12 dependent ER-phagy mechanism. The overall goal of the experiments included
in this proposal is to define nodes of cross-talk between the Hsp70 chaperone system, ERAD and ER-phagy
that are essential for cell viability and proteome maintenance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Detection of folding defects in mutant CFTR by ERQC
-
批准号:7925382
-
项目类别:
-
资助金额:$18.67万
-
财政年份:2009
-
负责人:DOUGLAS M CYR
-
依托单位:
MECHANISMS FOR SPECIFICATION OF HSP40 FUNCTION
-
批准号:7049278
-
项目类别:
-
资助金额:$3.94万
-
财政年份:2006
-
负责人:DOUGLAS M CYR
-
依托单位:
MECHANISMS FOR SPECIFICATION OF HSP40 FUNCTION
-
批准号:7359623
-
项目类别:
-
资助金额:$3.75万
-
财政年份:2006
-
负责人:DOUGLAS M CYR
-
依托单位:
MECHANISMS FOR SPECIFICATION OF HSP40 FUNCTION
-
批准号:7173853
-
项目类别:
-
资助金额:$3.82万
-
财政年份:2006
-
负责人:DOUGLAS M CYR
-
依托单位:
Hsp40 and Stress Protection
-
批准号:6889993
-
项目类别:
-
资助金额:$25.37万
-
财政年份:2003
-
负责人:DOUGLAS M CYR
-
依托单位:
Hsp40 and conformational disease
-
批准号:7380260
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2003
-
负责人:DOUGLAS M CYR
-
依托单位:
Hsp40 and Stress Protection
-
批准号:7052124
-
项目类别:
-
资助金额:$24.77万
-
财政年份:2003
-
负责人:DOUGLAS M CYR
-
依托单位:
Hsp40 and Stress Protection
-
批准号:6744186
-
项目类别:
-
资助金额:$25.37万
-
财政年份:2003
-
负责人:DOUGLAS M CYR
-
依托单位:
Hsp40 and conformational disease
-
批准号:7548135
-
项目类别:
-
资助金额:$32.65万
-
财政年份:2003
-
负责人:DOUGLAS M CYR
-
依托单位:
Hsp40 and conformational disease
-
批准号:7737661
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2003
-
负责人:DOUGLAS M CYR
-
依托单位:
Hsp40 and conformational disease
-
批准号:8011299
-
项目类别:
-
资助金额:$28.3万
-
财政年份:2003
-
负责人:DOUGLAS M CYR
-
依托单位:
Hsp40 and Stress Protection
-
批准号:6599047
-
项目类别:
-
资助金额:$25.37万
-
财政年份:2003
-
负责人:DOUGLAS M CYR
-
依托单位:
CHAPERONES AND THE BIOGENESIS OF MEMBRANE PROTEINS
-
批准号:6474958
-
项目类别:
-
资助金额:$14.51万
-
财政年份:1998
-
负责人:DOUGLAS M CYR
-
依托单位:
Detection of folding defects in mutant CFTR by ERQC
-
批准号:7340193
-
项目类别:
-
资助金额:$31.1万
-
财政年份:1998
-
负责人:DOUGLAS M CYR
-
依托单位:
Recognition of Defective CFTRdeltaF508 by Quality Control Machines
-
批准号:8457088
-
项目类别:
-
资助金额:$32.86万
-
财政年份:1998
-
负责人:DOUGLAS M CYR
-
依托单位:
Detection of folding defects in mutant CFTR by ERQC
-
批准号:7576083
-
项目类别:
-
资助金额:$31.1万
-
财政年份:1998
-
负责人:DOUGLAS M CYR
-
依托单位:
CHAPERONES AND THE BIOGENESIS OF MEMBRANE PROTEINS
-
批准号:2857347
-
项目类别:
-
资助金额:$18.93万
-
财政年份:1998
-
负责人:DOUGLAS M CYR
-
依托单位:
Chaperones and membrane protein biogenesis
-
批准号:7003806
-
项目类别:
-
资助金额:$28.6万
-
财政年份:1998
-
负责人:DOUGLAS M CYR
-
依托单位:
Recognition of Defective CFTRdeltaF508 by Quality Control Machines
-
批准号:8653961
-
项目类别:
-
资助金额:$34.05万
-
财政年份:1998
-
负责人:DOUGLAS M CYR
-
依托单位:
CHAPERONES AND THE BIOGENESIS OF MEMBRANE PROTEINS
-
批准号:2464866
-
项目类别:
-
资助金额:$20.89万
-
财政年份:1998
-
负责人:DOUGLAS M CYR
-
依托单位:
海外基金